BORAY — Bora Pharmaceuticals Co., Ltd./ADR

—
OTC · Unknown · Unknown · CIK 2097461 ·
Last close
$2.30
Market Cap
$293.37M
52W High
$7.00
52W Low
$2.30
ADV30
17
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 6,452,777,000 2,528,855,000 1,089,530,000 611,935,000 53,868,591,000 5,594,525,000 35,640,478,000
Jun 2026 5,889,454,000 2,430,225,000 986,641,000 555,763,000 52,077,131,000 8,431,018,000 34,541,633,000
Mar 2026 4,001,231,000 1,442,628,000 408,606,000 25,838,000 45,331,756,000 4,832,012,000 28,703,088,000
Dec 2025 4,860,654,000 1,772,261,000 557,571,000 331,759,000 44,714,187,000 5,076,889,000 27,241,998,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,123,455,000
Investing CF
$-3,480,558,000
Financing CF
$3,927,234,000
CapEx
$-1,160,714,000
Dividends Paid
$0
Buybacks
$-76,207,000
EPS Diluted TTM
$14.31
As of
2026-10-08

Balance + Analyst (yfinance extras)

Retained Earnings
$6,172,689,000
Inventory
$4,184,197,000
Receivables
—
ST Investments
$58,810,000
EBIT TTM
$3,224,530,000
Pretax Income TTM
$2,739,348,000
Interest Exp TTM
$485,182,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$19,557,484,544
EBITDA
$3,973,967,104
Free Cash Flow
$1,568,535,040
Enterprise Value
$17,423,044,608
Total Cash
$8,487,909,888
Total Debt
$21,815,470,080
Shares Out
127,552,019
Trailing EPS
$0.41
Book Value
$0.75
ROE
12.0%
ROA
4.0%
Div Yield
2.38%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 19,014,169,000 3,295,289,000 2,981,311,000 44,714,187,000 27,241,998,000 15,381,399,000 4,503,589,000
Dec 2024 17,426,624,000 3,708,000,000 3,852,515,000 45,509,645,000 30,586,316,000 12,779,166,000 980,024,000
Dec 2023 14,200,068,000 5,249,139,000 3,030,142,000 25,134,173,000 13,368,362,000 9,084,787,000 4,613,657,000
Dec 2022 10,494,470,000 1,922,176,000 1,391,916,000 22,761,215,000 17,620,759,000 4,528,322,000 2,010,074,000

Peers — same industry

TickerNameMarket CapLastDaily %
ASG LIBERTY ALL STAR GROWTH FUND INC. $293.10M $4.60 —
PPHC Public Policy Holding Company, Inc. $294.75M $9.64 —
CION CION Investment Corp $291.77M $5.93 —
FLXS FLEXSTEEL INDUSTRIES INC $295.71M $71.05 —
BGT BLACKROCK FLOATING RATE INCOME TRUST $295.86M $9.92 —

News headlines (Yahoo Finance, 1h cache)

UPSHER-SMITH LAUNCHES TWO STRENGTHS OF BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
2026-11-09 15:51 · Yahoo
Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets
2026-07-23 12:15 · Yahoo
Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations
2026-07-02 15:00 · Yahoo
UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
2026-05-20 14:00 · Yahoo
NTN (TSE:6472) Stock May Be 43% Undervalued Based On Cash Flow
2026-10-26 19:11 · Yahoo
UPSHER-SMITH LAUNCHES FLUVOXAMINE MALEATE EXTENDED-RELEASE CAPSULES
2026-09-30 16:45 · Yahoo
UPSHER-SMITH EXPANDS PORTFOLIO WITH LAUNCH OF GLATIRAMER ACETATE INJECTION
2026-08-20 14:00 · Yahoo
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
2026-07-15 00:00 · Yahoo
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
2026-07-02 13:25 · Yahoo
GMP Manufacturing Sale Gives MacroGenics Additional Non-Dilutive Capital for Pipeline Development (MGNX)
2026-05-12 15:08 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.